Article
Clinical utility of five genetic variants for predicting prostate cancer risk and mortality.
The Prostate - 1 Mar 2009
Salinas Claudia A, Koopmeiners Joseph S, Kwon Erika M, FitzGerald Liesel, Lin Daniel W, Ostrander Elaine A, Feng Ziding, Stanford Janet L
Abstract excerpt
BACKGROUND: A recent report suggests that the combination of five single-nucleotide polymorphisms (SNPs) at 8q24, 17q12, 17q24.3 and a family history of the disease may predict risk of prostate cancer. The present study tests the performance of these factors in prediction models for prostate cancer risk and prostate cancer-specific mortality. METHODS: SNPs were genotyped in population-based samples from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
